News
-
-
-
PRESS RELEASE
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
Abivax announces acceptance of 22 abstracts evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, featuring oral presentation on preclinical anti-fibrotic findings -
-
-
-
-
-
-